Management of metastatic prostate cancer largely depends on systemic therapy, 1 wherein androgen-deprivation therapy (ADT) remains the mainstay. 2 In this context, AstraZeneca Medical Team and Docplexus have organized an interactive webinar on 13 th August 2021 at 6:30 PM . Renowned experts Dr. A. K. Anand , Dr. N. Ragavan , and Dr.
Shailesh Raina will discuss the ‘Management of Prostate Cancer’ in this session. We invite you to share your questions here; the speakers will answer them at the end of the session. Agenda References: Ahmed ME, Jimbo M, Haloi R, Andrews JR, Motterle G, Joshi VB, Kendi AT, Stish BJ, Park SS, Karnes J, Kwon ED. Role of metastases-directed therapy (MDT) in the management of solitary metastatic prostate cancer. Journal of Clinical Oncology 2020 Feb;143-143. Payne H, Mason M. Androgen deprivation therapy as adjuvant/neoadjuvant to…
